Bausch & Lomb Corp
BLCO NYSEΒ· Ophthalmic Goods
Last close Β· Oct 26, 2026
$17.58
KIRA Β· Stoqlyβs AI analyst, in plain words
- Bausch & Lomb Corp had $5.1B of revenue in fiscal 2025, up 6.5% on the year before. Over five years, revenue changed +8.4% a year on average.
- Its operating margin was 2.2%, down 1.2Β pts: of every 100 in sales, about 2 is left after running the business.
- Bausch & Lomb Corp lost $360M in fiscal 2025.
- Free cash flow was β$66.0M in fiscal 2025, β1.3% of revenue.
- Bausch & Lomb Corp owes $4.7B more than it holds in cash, about 8.7 years of operating profit.
Market cap
$6.3B
P/E
β
Revenue
$5.1B
Net income
β$360M
Free cash flow
β$66.0M
Operating margin
2.2%
Bausch & Lomb Corp in 30 seconds Β· fiscal 2025
Are sales growing?
+6.5%
Yes. Sales grew 6.5% last year.
Does it make a profit?
β7.1%
No. It lost money last year.
Does profit turn into cash?
β1.3%
No. It spent more cash than it brought in.
Is debt under control?
8.7x
Heavy. Repaying its debt would take 8.7 years of operating profit.
How healthy are the accounts?
3 / 8
Weak. It passes 3 of 8 health tests.
How is the share priced?
β
No P/E: it made no profit over the last four quarters.
What Bausch & Lomb Corp does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Feb 18, 2026
- Legal name
- Bausch & Lomb Corp
- CIK
- 0001860742
Bausch & Lomb Corp Β· BLCO
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $3.8B | $3.8B | $4.1B | $4.8B | $5.1B |
| Revenue growth | 10.3% | 0.1% | 10.0% | 15.6% | 6.5% |
| Operating margin | 8.7% | 5.5% | 3.1% | 3.4% | 2.2% |
| Net income | $182M | $6.0M | β$260M | β$317M | β$360M |
| Net margin | 4.8% | 0.2% | β6.3% | β6.6% | β7.1% |
| Diluted EPS | $0.52 | $0.02 | β$0.74 | β$0.90 | β$1.02 |
| Cash | |||||
| Cash from operations | $873M | $345M | β$17.0M | $232M | $283M |
| Capital expenditure | $193M | $175M | $181M | $291M | $349M |
| Free cash flow | $680M | $170M | β$198M | β$59.0M | β$66.0M |
| FCF margin | 18.1% | 4.5% | β4.8% | β1.2% | β1.3% |
| Share count change | 0.0% | 0.1% | 0.1% | 0.4% | 0.6% |
| Debt and strength | |||||
| Cash and short-term investments | $174M | $354M | $331M | $305M | $383M |
| Debt incl. finance leases | $0.0M | $2.4B | $4.6B | $4.8B | $5.0B |
| Shareholders' equity | $9.3B | $7.0B | $6.9B | $6.5B | $6.4B |
| Net debt / EBITDA | β0.2x | 3.6x | 8.3x | 7.5x | 8.7x |
| Current ratio | 1.5x | 1.6x | 1.7x | 1.6x | 1.6x |
| Interest coverage | β | 1.4x | 0.5x | 0.4x | 0.3x |
| Returns and quality | |||||
| Return on capital | 2.3% | 1.5% | 0.9% | 1.2% | 0.8% |
| Return on equity | 1.9% | 0.1% | β3.7% | β4.8% | β5.6% |
| Return on tangible equity | 7.3% | 1.3% | β | β | β |
| Piotroski F-score | β | 4 | 2 | 3 | 3 |
| Altman Z'' | 7.4 | 2.4 | 1.7 | 1.4 | 1.2 |
Insiders bought, 12 months
$1.2M
9 insiders
Insiders sold, 12 months
$1.2M
2 insiders
Of sales under plans
0%
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Bausch & Lomb Corp Β· BLCO
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $17.58 a share, the company is worth $6.3B.
Source: SEC EDGAR XBRL filings (CIK 0001860742). Data updated October 24, 2026. For information only β not investment advice. Check the original filings before relying on any figure.
